Selected Publications for Anita Sjölander

• Topi G., Ehrnström R., Jirström K., Palmquist I., Lydrup M-L., Sjölander A.; Association of the oestrogen receptor beta with hormone status and prognosis in a cohort of female patients with colorectal cancer. European Journal of Cancer, 2017, 83:279-289. doi: 10.1016/j.ejca.2017.06.013. 
• Osman J.*, Savari S.*, Chandrashekar N.K., Bellamkonda K., Douglas D., and Sjölander A.; Cysteinyl leukotriene receptor 1 facilitates tumorigenesis in a mouse model of colitis-associated colon cancer. Oncotarget, 2017, e16718.
  *Equal contributors
• Mehdawi L., Satapathy S.R., Gustafsson Asting A., Lundholm K., Alvarado-Kristensson A. and Sjölander A.; A possible anti-tumor effect of leukotriene C₄ by inducing 15-hydroxyprostaglandin dehydrogenase expression in colon cancer cells. Oncotarget, 2017, e16591.
• Mehdawi M.L., Prasad C.P., Ehrnström R., Liu Q, Andersson T., and Sjölander A. Non-canonical WNT5A signaling up-regulates the expression of the tumor suppressor 15-PGDH and induces differentiation of colon cancer cells. Molecular Oncology, 2016, 10(9):1415-1429. Doi: 10.1016/j.molonc.2016.07.011
• Magnusson C., Mezhybovksa M., Lörinc E., Fernebro E., Nilbert M., and Sjölander A.; Low expression of CysLT₁R and high expression of CyLT₂R mediate good prognosis in colorectal cancer. European Journal of Cancer, 46:826-835, 2010.